The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia

Functional Neurology

Volumn 14, Issue 4, 1999, Pages 203-207

  Robles, Alfredo ^a,b   Touriño, Rosario ^a   Gude, Francisco ^a   Noya, Manuel ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b HOSPITAL GENERAL DE GALICIA   (Spain)

Author keywords

Alzheimer; Dementia; Frontotemporal dementia; Tropicamide

Indexed keywords

TROPICAMIDE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; OBSERVER VARIATION; PUPIL;

ADULT; AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYDRIATICS; OPHTHALMIC SOLUTIONS; PICK DISEASE OF THE BRAIN; PREDICTIVE VALUE OF TESTS; PUPIL; ROC CURVE; SENSITIVITY AND SPECIFICITY; TROPICAMIDE;

EID: 0033504766     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Scinto LFM, Daffner KR, Dressler D et al. A potential noninvasive neurobiological test for Alzheimer's disease. Science 1994;266:1051-1054
2. Paggiarino DA, Brancato LJ, Newton RE. The effect on pupil size and accommodation of sympathetic and parasympatholytic agents. Ann Ophthalmol 1993; 25:244-249,253
3. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944
4. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418
5. Feinstein AR. Clinical Epidemiology: The Architecture of Clinical Research. Philadelphia; W.B. Saunders Company 1985.
6. Scinto LFM, Daffner KR, Dressler D, Rentz D, Ransil BI, Potter H. Hypersensitivity pupillary dilation to a cholinergic antagonist as a diagnostic test for Alzheimer's disease. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski H eds Research Advances in Alzheimer's Disease and Related Disorders. John Wiley & Sons 1995:161-172
7. Gómez-Tortosa E, Del Barrio A, Jiménez-Alfaro I. Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders. Acta Neurol Scand 1996;94:104-109
8. Marx JL, Kumar SR, Thach AB, Kiat-Winarko T, Frambach DA. Detecting Alzheimer's disease. Science 1995;267:1577 (letter)
9. Arai H, Terajima M, Nakagawa T, Higuchi S, Mochizuki H, Sasaki H. Pupil dilation assay by tropicamide is modulated by apolipoprotein E epsilon 4 allele dosage in Alzheimer's disease. Neuroreport 1996;7: 918-920
10. Jaeschke R, Guyatt GH, Sackett DL, for the Evidence-Based Medicine Working Group. User's guide to the medical literature. III How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 1994;271:703-707
11. Greenhalgh T. How to read a paper. Papers that report diagnostic or screening tests. BMJ 1997;315:540-543
12. Loupe DN, Newman NJ, Green RC et al. Pupillary response to tropicamide in patients with Alzheimer's disease. Ophthalmology 1996; 103:495-503
13. Litvan I, FitzGibbon EJ. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects? Neurology 1996;47:1324-1326
14. Treolar A, Assin M, Macdonald A. Detecting Alzheimer's disease. Science 1995; 267:1578 (letter)